Antidepressant-like effect of hoodia gordonii in a forced swimming test in mice: Evidence for involvement of the monoaminergic system

Brazilian Journal of Medical and Biological Research

Volumn 48, Issue 1, 2015, Pages 57-64

  Cito M C O ^a   Silva, M I G ^a   Santos, L K X ^a   Fernandes, M L ^a   Melo, F H C ^a   Aguiar, J A C ^a   Lopes, I S ^a   Sousa, P B ^a   Vasconcelos, S M M ^a   Macedo D S ^a   Sousa, F C F ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Antidepressant action; Forced swimming test; Hoodia gordonii; Monoaminergic system

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL) PIPERAZINE; FENCLONINE METHYL ESTER; FLUOXETINE; HOODIA GORDONII EXTRACT; IMIPRAMINE; NEUROTRANSMITTER; ONDANSETRON; PLANT EXTRACT; PRAZOSIN; RITANSERIN; SULPIRIDE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; FORCED SWIM TEST; IMMOBILITY; LOCOMOTION; MALE; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; OPEN FIELD TEST; QUALITY CONTROL; SEROTONIN BLOOD LEVEL;

HOODIA GORDONII; MUS;

EID: 84916912423     PISSN: None     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20144215     Document Type: Article

References (36)

1. Wong ML, Licinio J. Research and treatment approaches to depression. Nat Rev Neurosci 2001; 2: 343-351, doi: 10.1038/35072566.
2. Tran PV, Bymaster FP, McNamara RK, Potter WZ. Dual monoamine modulation for improved treatment of major depressive disorder. J Clin Psychopharmacol 2003; 23: 78-86. doi: 10.1097/00004714-200302000-00011.
3. Dhingra D, Valecha R. Evidence for involvement of the monoaminergic system in antidepressant-like activity of an ethanol extract of Boerhaavia diffusa and its isolated constituent, punarnavine, in mice. Pharm Biol 2014; 52: 767-774, doi: 10.3109/13880209.2013.870583.
4. Teixeira CP, de Melo CT, de Araujo FL, de Carvalho AM, Silva MI, Barbosa-Filho JM, et al. Antidepressant-like effect of riparin II from Aniba riparia in mice: evidence for the involvement of the monoaminergic system. Fundam Clin Pharmacol 2013; 27: 129-137, doi: 10.1111/j.1472-8206.2011.00973.x.
5. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine 2000; 7: 463-469, doi: 10.1016/S0944-7113(00)80030-6.
6. van Heerden FR. Hoodia gordonii: a natural appetite suppressant. J Ethnopharmacol 2008; 119: 434-437, doi: 10.1016/j.jep.2008.08.023.
7. van Heerden FR, Marthinus HR, Maharaj VJ, Vleggaar R, Senabe JV, Gunning PJ. An appetite suppressant from Hoodia species. Phytochemistry 2007; 68: 2545-2553, doi: 10.1016/j.phytochem.2007.05.022.
8. Blom WA, Abrahamse SL, Bradford R, Duchateau GS, Theis W, Orsi A, et al. Effects of 15-d repeated consumption of Hoodia gordonii purified extract on safety, ad libitum energy intake, and body weight in healthy, overweight women: a randomized controlled trial. Am J Clin Nutr 2011; 94: 1171-1181, doi: 10.3945/ajcn.111.020321.
9. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336.
10. Chen PJ, Hsieh CL, Su KP, Hou YC, Chiang HM, Sheen LY. Rhizomes of Gastrodia elata B(L) possess antidepressantlike effect via monoamine modulation in subchronic animal model. Am J Chin Med 2009; 37: 1113-1124, doi: 10.1142/S0192415X09007533.
11. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 2002; 23: 238-245, doi: 10.1016/S0165-6147(02)02017-5.
12. do Amaral JF, Silva MI, de Aquino Neto MR, Moura BA, de Carvalho AM, Vasconcelos PF, et al. Antidepressant-like effect of bis-eugenol in the mice forced swimming test: evidence for the involvement of the monoaminergic system. Fundam Clin Pharmacol 2013; 27: 471-482, doi: 10.1111/j.1472-8206.2012.01058.x.
13. Einat H, Clenet F, Shaldubina A, Belmaker RH, Bourin M. The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors. Behav Brain Res 2001; 118: 77-83, doi: 10.1016/S0166-4328(00)00314-4.
14. Machado DG, Kaster MP, Binfare RW, Dias M, Santos AR, Pizzolatti MG, et al. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 421-428, doi: 10.1016/j.pnpbp.2006.11.004.
15. Posser T, Kaster MP, Barauna SC, Rocha JB, Rodrigues AL, Leal RB. Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system. Eur J Pharmacol 2009; 602: 85-91, doi: 10.1016/j.ejphar.2008.10.055.
16. Melo CT, de Carvalho AM, Moura BA, Teixeira CP, Vasconcelos LF, Feitosa ML, et al. Evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the antidepressant-like action of riparin III obtained from Aniba riparia (Nees) Mez (Lauraceae) in mice. Fundam Clin Pharmacol 2013; 27: 104-112, doi: 10.1111/j.1472-8206.2011.00968.x.
17. Archer J. Tests for emotionality in rats and mice: a review. Anim Behav 1973; 21: 205-235, doi: 10.1016/S0003-3472(73)80065-X.
18. Petit-Demouliere B, Chenu F, Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology 2005; 177: 245-255, doi: 10.1007/s00213-004-2048-7.
19. Silva MI, de Aquino Neto MR, Teixeira Neto PF, Moura BA, do Amaral JF, de Sousa DP, et al. Central nervous system activity of acute administration of isopulegol in mice. Pharmacol Biochem Behav 2007; 88: 141-147, doi: 10.1016/j.pbb.2007.07.015.
20. Porsolt RD, Bertin A, Jalfre M. ‘‘Behavioural despair’’ in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 1978; 51: 291-294, doi: 10.1016/0014-2999(78)90414-4.
21. Refaey HEL, Amri HS. Effects of antidepressants on behavioral assessment in adolescent rats. Bahrain Med Bull 2014; 33: 1-12.
22. Walsh RN, Cummins RA. The Open-Field Test: a critical review. Psychol Bull 1976; 83: 482-504, doi: 10.1037/0033-2909.83.3.482.
23. Nielsen JA, Shannon NJ, Bero L, Moore KE. Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons. Pharmacol Biochem Behav 1986; 24: 795-799, doi: 10.1016/0091-3057(86)90413-2.
24. Reus GZ, Abelaira HM, dos Santos MA, Carlessi AS, Tomaz DB, Neotti MV, et al. Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors. Behav Brain Res 2013; 256: 451-456, doi: 10.1016/j.bbr.2013.08.041.
25. Cardoso CC, Lobato KR, Binfare RW, Ferreira PK, Rosa AO, Santos AR, et al. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 235-242, doi: 10.1016/j.pnpbp.2008.11.007.
26. Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 435-451, doi: 10.1016/j.pnpbp.2003.11.018.
27. Stahl SM, Lee-Zimmerman C, Cartwright S, Morrissette DA. Serotonergic drugs for depression and beyond. Curr Drug Targets 2013; 14: 578-585, doi: 10.2174/1389450111314050007.
28. O’Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. Psychopharmacology 2007; 192: 357-371, doi: 10.1007/s00213-007-0728-9.
29. Kitada Y, Miyauchi T, Kanazawa Y, Nakamichi H, Satoh S. Involvement of alpha- and beta 1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming test. Neuropharmacology 1983; 22: 1055-1060, doi: 10.1016/0028-3908(83)90024-2.
30. Stone EA, Grunewald GL, Lin Y, Ahsan R, Rosengarten H, Kramer HK, et al. Role of epinephrine stimulation of CNS alpha1-adrenoceptors in motor activity in mice. Synapse 2003; 49: 67-76, doi: 10.1002/syn.10212.
31. D’Aquila PS, Collu M, Gessa GL, Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 2000; 405: 365-373, doi: 10.1016/S0014-2999(00)00566-5.
32. Dziedzicka-Wasylewska M, Kolasiewicz W, Rogoz Z, Margas W, Maj J. The role of dopamine D2 receptor in the behavioral effects of imipramine - study with the use of antisense oligonucleotides. J Physiol Pharmacol 2000; 51: 401-409.
33. Yamada J, Sugimoto Y, Yamada S. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol 2004; 504: 207-211, doi: 10.1016/j.ejphar.2004.09.057.
34. Butterweck V, Bockers T, Korte B, Wittkowski W, Winterhoff H. Long-term effects of St. John’s wort and hypericin on monoamine levels in rat hypothalamus and hippocampus. Brain Res 2002; 930: 21-29, doi: 10.1016/S0006-8993(01)03394-7.
35. Kreiss DS, Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5- hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 1995; 274: 866-876.
36. Ichikawa J, Meltzer HY. Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur J Pharmacol 1995; 281: 255-261, doi: 10.1016/0014-2999(95)00264-L.